CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $39.93 million. The enterprise value is $31.52 million.

Market Cap	39.93M
Enterprise Value	31.52M

Important Dates

The last earnings date was Wednesday, August 20, 2025, before market open.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CLGN has 12.72 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	12.72M
Shares Outstanding	12.72M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+3.37%
Owned by Insiders (%)	29.07%
Owned by Institutions (%)	14.55%
Float	8.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.10
PS Ratio	15.10
Forward PS	2.26
PB Ratio	3.19
P/TBV Ratio	3.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.24.

Current Ratio	4.60
Quick Ratio	4.30
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.25% and return on invested capital (ROIC) is -42.07%.

Return on Equity (ROE)	-78.25%
Return on Assets (ROA)	-37.90%
Return on Invested Capital (ROIC)	-42.07%
Return on Capital Employed (ROCE)	-90.79%
Revenue Per Employee	$42,140
Profits Per Employee	-$228,123
Employee Count	57
Asset Turnover	0.11
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.38% in the last 52 weeks. The beta is 0.81, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-35.38%
50-Day Moving Average	2.57
200-Day Moving Average	2.73
Relative Strength Index (RSI)	67.85
Average Volume (20 Days)	12,460

Short Selling Information

Short Interest	36,343
Short Previous Month	41,626
Short % of Shares Out	0.41%
Short % of Float	n/a
Short Ratio (days to cover)	1.22

Income Statement

In the last 12 months, CLGN had revenue of $2.40 million and -$13.00 million in losses. Loss per share was -$1.13.

Revenue	2.40M
Gross Profit	1.48M
Operating Income	-13.34M
Pretax Income	-13.00M
Net Income	-13.00M
EBITDA	-12.37M
EBIT	-13.34M
Loss Per Share	-$1.13

Full Income Statement

Balance Sheet

The company has $11.43 million in cash and $3.03 million in debt, giving a net cash position of $8.41 million or $0.66 per share.

Cash & Cash Equivalents	11.43M
Total Debt	3.03M
Net Cash	8.41M
Net Cash Per Share	$0.66
Equity (Book Value)	12.51M
Book Value Per Share	0.98
Working Capital	9.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.52 million and capital expenditures -$211,000, giving a free cash flow of -$10.73 million.

Operating Cash Flow	-10.52M
Capital Expenditures	-211,000
Free Cash Flow	-10.73M
FCF Per Share	-$0.84

Full Cash Flow Statement

Margins

Gross Margin	61.78%
Operating Margin	-555.45%
Pretax Margin	-541.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	-32.57%
FCF Yield	-26.87%

Analyst Forecast

The average price target for CLGN is $11.50, which is 272.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	272.17%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	1:1.5

Scores

CLGN has an Altman Z-Score of -6.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.1
Piotroski F-Score	3